Cargando…
Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome
Autores principales: | Uzokov, J, Alyavi, A, Alyavi, B, Azizov, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312754/ https://www.ncbi.nlm.nih.gov/pubmed/32612687 http://dx.doi.org/10.15420/ecr.2020.15.1.PO4 |
Ejemplares similares
-
Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Amalia, Maya Rosana, et al.
Publicado: (2021) -
Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy
por: Matsuda, M
Publicado: (2020) -
Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: Dastan, F
Publicado: (2020) -
Best Poster Award – Third Prize: The Perilousness of Antidepressant Drugs in a Real-world Cohort of Patients with Acute Coronary Syndrome
por: Denegri, A, et al.
Publicado: (2020) -
A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
por: Matsuda, M, et al.
Publicado: (2020)